Randomized controlled trial that evaluate efficacy of therapeutic intervention for ulcerative colitis patients with the Mayo endoscopic score of 1.
Not Applicable
Recruiting
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000031556
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with colitis except for Ulcerative colitis. Patients with gastrointestinal obstruction. Preoperation patients. Patients with severe infection. Patients with malignancy or history of malignancy. Patients received anti TNF a antibody, tacrolimus or topical therapy. Inappropriate patients by doctor's judgement.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method disease relapse for 1 year.
- Secondary Outcome Measures
Name Time Method Relationship between fecal calprotectin and relapse rate Relationship between UCEIS and relapse rate Relationship between dosage of 5ASA and relapse rate Contents of additional treatment after relapse Transition of pMayo during the observation period Relationship between adherence and relapse Safety